Anonymous
Guest
Anonymous
Guest
chirp, chirp. just like nexium. won't lower the price or come up with a card of equal value or some way to compete against such a great pricing deal for patients and managed care. foolishly, they think crestor offers enough clinical advantages to offset the price differential even though the patients are on mulitple meds and the economy is as bad as it is. business geniuses.